The New Republic has an insightful article talking about the
“absence of truly innovative drugs in current drug company pipelines. And the explanation for that might well come from the supposed fount of American innovation: our patent system.” Apparently they are trapped in a situation where “it’s much easier to argue that `patents support innovation’ than to try to explain that some patents are good for innovation while others are bad.” A long read, but unlike the latest copy-protected mp3 player, this is definitely stuff that matters!”